Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions
Abstract
Biologics, both monoclonal antibodies (mAbs) and fusion proteins, have revolutionized the practice of medicine. This year marks the 30th anniversary of the Food and Drug Administration approval of the first mAb for human use. In this review, we examine the biotechnological breakthroughs that spurred the explosive development of the biopharmaceutical mAb industry, as well as how critical lessons learned about human immunology informed the...
Paper Details
Title
Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions
Published Date
Nov 1, 2016
Journal
Volume
34
Issue
6
Pages
1149 - 1158
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History